— Know what they know.
Not Investment Advice

RGDXQ OTC

Response Genetics, Inc
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -0.0% 5Y: -95.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 53 · $3873 mcap · 33M float · 0.215% daily turnover

Balance Sheet Trends

Total Assets
$49M +263.6% ▲
5Y CAGR: +35.8%
Total Liabilities
$16M +8.6% ▲
5Y CAGR: +2.7%
Shareholders Equity
$33M +2921.7% ▲
Cash & Investments
$19M +775.5% ▲
5Y CAGR: +36.4%
Total Debt
$6M -34.1% ▼
Net Debt
-$13M -275.8% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2011FY2012FY2013FY2014FY2015
— Assets —
Cash$2M$9M$8M$2M$19M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$2M$9M$8M$2M$19M
Net Receivables$4M$5M$6M$8M$7M
Inventory$0$0$0$0$133K
Other Current Assets$0$0$0$10K$0
Total Current Assets$7M$15M$15M$11M$28M
Property, Plant & Equip.$1M$1M$2M$1M$6M
Goodwill & Intangibles$44K$575K$767K$631K$14M
Long-Term Investments$0$0$0$0$341K
Other Non-Current Assets$0$0$0$192K$520K
Total Non-Current Assets$1M$2M$3M$2M$21M
Total Assets$8M$17M$18M$13M$49M
— Liabilities —
Accounts Payable$1M$1M$2M$2M$0
Short-Term Debt$1M$1M$0$682K$1M
Deferred Revenue$0$483K$4M$0$831K
Other Current Liabilities$2M$1M$2M$1M$8M
Total Current Liabilities$6M$5M$6M$5M$10M
Long-Term Debt$0$0$1M$7M$5M
Other Non-Current Liab.$8M$12M$6M$3M$315K
Total Non-Current Liabilities$8M$12M$7M$10M$6M
Total Liabilities$14M$17M$12M$15M$16M
— Equity —
Common Stock$134K$232K$337K$388K$1K
Retained Earnings-$50M-$57M-$65M-$79M-$98M
Accumulated OCI-$267K-$264K-$267K-$260K$0
Total Stockholders Equity-$6M-$542K$6M-$1M$33M
Total Liabilities & Equity$8M$17M$18M$13M$49M
— Key Metrics —
Total Debt$1M$1M$1M$10M$6M
Net Debt-$310K-$8M-$7M$7M-$13M
Total Investments$0$0$0$0$341K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms